Catalogo Articoli (Spogli Riviste)

OPAC HELP

Titolo:
Recombinant human follicle-stimulating hormone for ovulation induction in polycystic ovary syndrome: A prospective, randomized trial of two starting doses in a chronic low-dose step-up protocol
Autore:
Balasch, J; Fabregues, F; Creus, M; Casamitjana, R; Puerto, B; Vanrell, JA;
Indirizzi:
Univ Barcelona, Inst Clin Gynecol Obstet & Neonatol, Fac Med, Hosp Clin,Inst Invest Biomed August Pi & Sunyer, Barcelona, Spain Univ Barcelona Barcelona Spain med August Pi & Sunyer, Barcelona, Spain
Titolo Testata:
JOURNAL OF ASSISTED REPRODUCTION AND GENETICS
fascicolo: 10, volume: 17, anno: 2000,
pagine: 561 - 565
SICI:
1058-0468(200011)17:10<561:RHFHFO>2.0.ZU;2-3
Fonte:
ISI
Lingua:
ENG
Soggetto:
HUMAN MENOPAUSAL GONADOTROPIN; HYPOGONADOTROPIC HYPOGONADISM; MULTIPLE BIRTHS; WOMEN; INFERTILITY; INHIBIN;
Keywords:
follicle-stimulating hormone; ovulation induction; polycystic ovary syndrome; recombinant human FSH;
Tipo documento:
Article
Natura:
Periodico
Settore Disciplinare:
Clinical Medicine
Citazioni:
26
Recensione:
Indirizzi per estratti:
Indirizzo: Balasch, J Inst Clin Gynecol Obstet & Neonatol, C Casanova 143, Barcelona 08036, Spain Inst Clin Gynecol Obstet & Neonatol C Casanova 143 Barcelona Spain 08036
Citazione:
J. Balasch et al., "Recombinant human follicle-stimulating hormone for ovulation induction in polycystic ovary syndrome: A prospective, randomized trial of two starting doses in a chronic low-dose step-up protocol", J AS REPROD, 17(10), 2000, pp. 561-565

Abstract

Purpose: The aim was to compare the follicular response to 37.5 and 50 IU of recombinant follicle-simulating hormone (FSH) as starting doses for ovulation induction in patients with polycystic ovary syndrome (PCOS). Methods: Prospective, randomized crossover study including 15 women with clomiphene citrate-resistant chronic anovulatory infertility. Patients were treated with subcutaneous recombinant FSH at starting doses of 37.5 IU and 50 IU, respectively according to a low-dose step-up protocol. Each woman received both treatments, in a randomized or der, with an interval of greaterthan or equal to1 month between treatments. Results: All treatment cycles were ovulatory after an appropriate follicular response and hormone levels were similar with both treatments, althorlghthe total quantity of FSH required and the mean daily dose required to induce identical follicular development were significantly lower with a starting dose of 37.5 IU FSH. The mean duration of treatment to achieve ovulationwas approximately 13 days with both treatments but treatment periods greater than or equal to 20 days were required in some patients. Conclusions: In women with PCOS, a starting dose of 37.5 IU recombinant FSH may be adequate to induce follicular growth. However; the rise of low stal ring doses mcay result in some cases in increased treatment periods and need for monitoring.

ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 04/12/20 alle ore 13:13:10